Gefticip 250mg tablet

Gefticip 250mg tablet

Prescription requiredRx Required

Salt Composition: Gefitinib

Expiry Date: 01/2028

Special offer

Buy at $55.26

$55.26

Inclusive of all taxes

30 tablet

About The Product

Lung Cancer

Gefticip 250mg tablet is a chemotherapy medication that is used in the treatment of non-small cell lung cancer (NSCLC). The generic name of this medication is Gefitinib. It is a tyrosine kinase inhibitor that shows antineoplastic activity. Gefticip is used in the first-line treatment of lung cancer that has genetic mutations.

Side Effects

  • Every medicine has some side effects that manage on their own as your body gets used to the medicine, but some people may rarely experience severe side effects.
  • In that case, the patient should contact the doctor immediately.
  • Some common side effects of Entekor 1mg Tablet include: Mouth sores Dry skin Loss of appetite Blisters of skin Vomiting Hives on the skin Shortness of breath Dark coloration of urine Yellowing of skin and eyes Nausea Sensitivity to light Vision complications Acne Extreme weakness Diarrhea Seek medical attention in case of any unusual or severe side effects immediately.

How To Use

  • The dosage and treatment duration of the Gefticip 250mg tablet are decided by the doctor according to the stage of cancer and the overall patient's health.
  • This tablet should be taken with or without food, but at the fix time every day to get effective results.
  • Don't miss a dose or overdose on the medicine.

Safety Advice

Alcohol
Avoid the consumption of alcohol while taking Gefticip 250mg tablet, as alcohol can reduce the effectiveness of the medicine and worsen the symptoms
Pregnancy
Do not take the Gefticip 250mg tablet without consulting the doctor in case of pregnancy, as it is an unsafe medicine during this period.
Breast Feeding
Gefticip 250mg tablet is dangerous to use during breastfeeding as it may cause toxicity to the baby.
Driving
Gefticip 250mg tablet may cause side effects such as dizziness or impaired concentration, which could affect your ability to drive safely. So it's better to avoid driving or operating heavy machinery.
Kidney
Consumption of Gefticip 250mg tablet should be avoided without informing the doctor if you have any kidney-related issues.
Liver
Gefticip 250mg tablet is safe for use in liver disease. No dosage adjustment is necessary for this Tablet.

Missed Doses

  • ​ It is advisable to avoid missing any doses of Gefticip and in case you miss a dose of Gefticip consult your doctor immediately.

FAQs

​ Gefticip 250mg tablet is an anticancer medication that is primarily used in the treatment of lung cancer.

Reference

1. Uhm, J.

H., Ballman, K. V., Wu, W., Giannini, C., Krauss, J.

C., Buckner, J. C., ... & Jaeckle, K.

A. (2011).

Phase II evaluation of gefitinib in patients with newly diagnosed Grade 4 astrocytoma: Mayo/North Central Cancer Treatment Group Study N0074. International Journal of Radiation Oncology* Biology* Physics, 80(2), 347-353.

2. Herbst, R.

S., Fukuoka, M., & Baselga, J. (2004).

Gefitinib—a novel targeted approach to treating cancer. Nature Reviews Cancer, 4(12), 956-965.

3. Rawluk, J., & Waller, C.

F. (2018).

Gefitinib. Small molecules in oncology, 235-246.

4. Giaccone, G.

(2004). The role of gefitinib in lung cancer treatment.

Clinical cancer research, 10(12), 4233s-4237s. 5.

Höpfner, M., Sutter, A. P., Huether, A., Schuppan, D., Zeitz, M., & Scherübl, H.

(2004). Targeting the epidermal growth factor receptor by gefitinib for treatment of hepatocellular carcinoma.

Journal of hepatology, 41(6), 1008-1016. 6.

Araki, T., Yashima, H., Shimizu, K., Aomori, T., Hashita, T., Kaira, K., ... & Yamamoto, K. (2012).

Review of the treatment of non-small cell lung cancer with gefitinib. Clinical Medicine Insights: Oncology, 6, CMO-S7340.

i
Trust & safety

Medical Disclaimer

Accurate, reviewed information to support informed healthcare decisions

For informational purposes only
Not a substitute for professional medical advice
Consult your doctor for diagnosis and treatment

Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.

The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.

This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.

Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.

Always follow advice from your doctor, pharmacist, or other licensed healthcare professional before starting, stopping, or changing any medicine or treatment.
Magicine PharmacopyCopyright 2026